| Literature DB >> 26021205 |
Christian G Peyre1, Thomas J Watson2.
Abstract
Patients with gastroesophageal reflux disease and Barrett's esophagus can be a management challenge for the treating physician or surgeon. The goals of therapy include relief of reflux symptoms, induction of histologic regression, and prevention of progression of intestinal metaplasia to dysplasia or invasive carcinoma. Antireflux surgery is effective at achieving these end points, although ongoing follow-up and endoscopic surveillance are essential. In cases of dysplasia or early esophageal neoplasia associated with Barrett's esophagus, endoscopic resection and ablation have supplanted esophagectomy as the standard of care in most cases. Esophageal resection continues to have a role, however, in a minority of appropriately selected candidates.Entities:
Keywords: Antireflux surgery; Barrett’s esophagus; Esophagectomy; Intramucosal adenocarcinoma; Nissen fundoplication
Mesh:
Substances:
Year: 2015 PMID: 26021205 DOI: 10.1016/j.gtc.2015.02.013
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806